Hutchmed China Ltd - Company Profile

Powered by

All the sales intelligence you need on Hutchmed China Ltd in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Hutchmed China Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Hutchmed China Ltd.

Back to companies

Hutchmed China Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on Hutchmed China Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Hutchmed China Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Johnny CHENG

Chief Executive Officer - Acting; Chief Financial Officer; Director Executive Board Age: 59

Mr Johnny Cheng has been the Director, Chief Financial Officer and Acting Chief Executive Officer of the company since August 2025. Prior to this, he served as the vice president, finance at Bristol Myers Squibb. Previously, he served as the Director at Sino-American Shanghai Squibb Pharmaceuticals Ltd. and Bristol-Myers Squibb (China) Investment Co. Ltd.

Read Hide full bio of Johnny CHENG

Steven Hu

Head - Commercial (China); Executive Vice President Senior Management

Mr Steven Hu serves as the Executive Vice President and Chief Technical Officer of the company. Prior to this, he served as the Chief Technology Officer at Everest Medicines, Asymchem Laboratories Group, and Hengrui.

Read Hide full bio of Steven Hu

Dan Eldar, PhD

Chairman Non Executive Board Since: 2024 Age: 72

Mr. Dan Eldar has been the Chairman of the company since 2024. Prior to this, he served as the Executive Director of Hutchison Water. Previously, he served as the Managing Director of Longliv Ventures Digital Health Fund. Mr. Eldar also served as the Member of the Board of Directors of Sight Diagnostics.

Read Hide full bio of Dan Eldar, PhD

Weiguo SU

Chief Scientific Officer; Chief Executive Officer; Director Executive Board Since: 2022 Age: 68

David NG

Head - Investor Relations and Capital Strategies Senior Management
Gain a 360-degree view of Hutchmed China Ltd and make more informed decisions for your business Gain a 360-degree view of Hutchmed China Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer